NIH-funded research R01 grant

Understanding how specific proteins help heal the heart after injury

Official title: Chaperone-Mediated Autophagy in Cardiac Fibrosis

Funded at Albert Einstein College of Medicine · NIH-11133283 · Data updated 2026-11-12

This study is looking at how a special process in our cells helps heart repair after damage, like from a heart attack, and it focuses on understanding how this affects the cells that help heal the heart, especially in older adults.

More Fibrosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startMay 1, 2025
Project endFebruary 28, 2029
Funding year2025
Award (this year)$785,198
NIH project number1R01HL174940-01A1
Project IDNIH-11133283 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults who have experienced heart damage, such as from a heart attack.

Less likely to help

Patients with non-cardiac conditions or those who have not experienced heart damage may not benefit from this research.

What this research studies

This research investigates the role of Chaperone-Mediated Autophagy (CMA) in the healing process of the heart following damage, such as a heart attack. It focuses on how fibroblasts, which are crucial for heart repair, change their behavior and function during this process. By examining how CMA affects these cells, the research aims to uncover new insights into improving heart repair and function, especially in older patients where this process may be impaired. The study will involve various experimental approaches to analyze the effects of CMA on fibroblast activity and heart recovery.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance heart repair and function after injury, particularly for older patients.

How similar studies have gone: Previous research has shown that targeting cellular processes like CMA can improve heart repair, suggesting a promising avenue for this investigation.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Frangogiannis, Nikolaos G — Albert Einstein College of Medicine
  • Study coordinator: Frangogiannis, Nikolaos G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.